NCT07856472 AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study
| NCT ID | NCT07856472 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Inha University Hospital |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2028-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-03-01 with a primary completion date of 2028-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter retrospective study aims to develop, validate, and clinically apply an artificial intelligence (AI)-powered electrocardiography (ECG) algorithm for the diagnosis and prognostic prediction of cardiovascular diseases, including coronary artery disease and heart failure. By utilizing encrypted raw 12-lead ECG text data and deep neural network models, the study evaluates the effectiveness of AI-enhanced ECG in detecting cardiac abnormalities and predicting clinical outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years or older diagnosed with cardiovascular diseases, including coronary artery disease and heart failure. * Patients with 12-lead electrocardiogram (ECG) records extractable as text (XML Exclusion Criteria: \- Patients deemed inappropriate as study subjects by the investigator's judgment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07856472 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07856472 currently recruiting?
Yes, NCT07856472 is actively recruiting participants. Contact the research team at existsoo@inha.ac.kr for enrollment information.
Where is the NCT07856472 trial being conducted?
This trial is being conducted at Incheon, South Korea.
Who is sponsoring the NCT07856472 clinical trial?
NCT07856472 is sponsored by Inha University Hospital. The trial plans to enroll 10,000 participants.